(A) Nomenclature of extracellular vesicles and particles employed in this study.
(B) Immunoblots of DKO-1 and Gli36 whole cell lysates, large EVs (P15) and crude small EVs (P120) (STAR Methods). Equal quantities of protein were separated on SDS-PAGE gels, and membranes were blotted with indicated antibodies.
(C) Density gradient fractionation of DKO-1 and Gli36 crude small EVs (P120). After flotation of sample in high-resolution iodixanol gradients (STAR Methods), equal volumes of each fraction were loaded on SDS-PAGE gels, and membranes were blotted with indicated antibodies. NV, non-vesicular; sEV, small EV.
(D) Nanoparticle tracking analysis of pooled low (sEV) and high (non-vesicular) density fractions with or without pre-treatment with Triton X-100 detergent. For box plots the center lines mark the median; box limits indicate 25th and 75th percentiles; whiskers extend 1.5 times the interquartile range from 25th and 75th percentiles; n = 18 sample points; data from three independent experiments. Significant differences were assessed by one-way ANOVA and pairwise comparisons adjusted by the Holm-Bonferroni method; *p < 0.001; N.S., Not Significant.
(E) Negative stain transmission electron microscopy (TEM) of DKO-1 large EVs (P15), and pooled low (sEV) and high (NV) fractions obtained from high-resolution density gradients.
(F) Negative stain TEM of Gli36 pooled low (sEV) and high (NV) fractions. See also Figure S1 and Table S1.